Actively Recruiting
Evaluating the Safety and Effectiveness of the Minimally Invasive Micro Sclerostomy MIMS4 Device to Lower Eye Pressure in Adults with Open-Angle Glaucoma Not Controlled by Medication
Led by Sanoculis Ltd · Updated on 2024-08-07
129
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What this Trial Is About
Researchers are evaluating the Minimally Invasive Micro Sclerostomy MIMS4 device and procedure to reduce intraocular pressure in people with primary open angle glaucoma that is not controlled despite multiple medications. The study aims to show that the MIMS4 procedure with Mitomycin-C is not less effective than traditional trabeculectomy with Mitomycin-C in controlling eye pressure. This is a single-arm, interventional clinical trial sponsored by Sanoculis Ltd.
CONDITIONS
Brief Title
Safety and Effectiveness of Minimally Invasive Micro Sclerostomy (MIMS®) to Reduce Intraocular Pressure in Open-Angle Glaucoma Which is Not Controlled Despite Polypharmacy
Research Team
K
Khan Lau, OD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
